The University is collaborating on ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.
Led by the Royal Devon University Healthcare NHS Foundation Trust alongside Devon Partnership NHS Trust, the studies involve using regulated forms of psychedelic drugs. These innovative therapies could prove effective for treating conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD).
One in six people are thought to be living with a mental health condition in the UK and may experience distressing symptoms, which are often managed through therapy and medication.
Professor Celia Morgan from the University of Exeter is leading the work and said: "Psychedelic treatments provide new hope for individuals living with PTSD and major depressive disorder (MDD), especially those who have not responded to existing treatments.
"Psychedelics can help people to gain new perspectives and process deep emotions, and may also benefit those with PTSD and depression. However, more research is needed to fully understand how these treatments might help across conditions."
